Bioprocessing News and Research

RSS
Cellular Origins acquires Actia Platform IP to enhance automated cell therapy manufacturing

Cellular Origins acquires Actia Platform IP to enhance automated cell therapy manufacturing

H.E.L Group extends sales and support with appointment of specialist distributors

H.E.L Group extends sales and support with appointment of specialist distributors

H.E.L Group extends sales and support with appointment of specialist distributors

H.E.L Group extends sales and support with appointment of specialist distributors

Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

Phase 1 trial for EBC-129 progresses into dose expansion

Phase 1 trial for EBC-129 progresses into dose expansion

ArgusEye closes €2.8 million funding to accelerate bioprocessing

ArgusEye closes €2.8 million funding to accelerate bioprocessing

ArgusEye introduces AugaOne to accelerate downstream bioprocess development

ArgusEye introduces AugaOne to accelerate downstream bioprocess development

Discover the BIOne 250: A Budget Friendly Bioprocess Control Station for Microbial Applications

Discover the BIOne 250: A Budget Friendly Bioprocess Control Station for Microbial Applications

ATCC announces new award from BARDA to provide centralized storage and bioprocessing services for Project NextGen

ATCC announces new award from BARDA to provide centralized storage and bioprocessing services for Project NextGen

Small molecule applications of process Raman spectroscopy

Small molecule applications of process Raman spectroscopy

Empowering oncology research: Transmembrane proteins and cutting-edge production platforms

Empowering oncology research: Transmembrane proteins and cutting-edge production platforms

MaxCyte joins the alliance for mRNA medicines (AMM) as a founding member

MaxCyte joins the alliance for mRNA medicines (AMM) as a founding member

Groundbreaking technology developed to extract mesenchymal stem cells from pure bone marrow

Groundbreaking technology developed to extract mesenchymal stem cells from pure bone marrow

MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing

Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing

Innovations in baculovirus–insect cell expression systems

Innovations in baculovirus–insect cell expression systems

Using CRISPR gene-editing system to build a more sustainable forest

Using CRISPR gene-editing system to build a more sustainable forest

Next-Generation EV Separation: Izon Science and Agarose Bead Technologies Collaborate to Enhance Clinical Applications for Extracellular Vesicles

Next-Generation EV Separation: Izon Science and Agarose Bead Technologies Collaborate to Enhance Clinical Applications for Extracellular Vesicles

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.